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Primary immunodeficiency diseases (PID) is a heterogeneous group of disorders caused
by genetic defects of the immune system, which manifests clinically as recurrent
infections, autoimmune diseases, or malignancies. Early detection of other PID remains
a challenge, particularly in older children due to milder and less specific symptoms,
a low level of clinician PID awareness and poor provision of hospital laboratories
with appropriate devices. T-cell recombination excision circles (TREC) and kappa-
deleting element recombination circle (KREC) in a dried blood spot and in peripheral
blood using real-time polymerase chain reaction (PCR) are used as a tool for severe
combined immune deficiency but not in PID. They represent an attractive and cheap
target for a more extensive use in clinical practice. This study aimed to assess
TREC/KREC correspondence with lymphocyte subpopulations, measured by flow
cytometry and evaluate correlations between TREC/KREC, lymphocyte subpopulations
and immunoglobulins. We carried out analysis of data from children assessed by clinical
immunologists at Speransky Children’s Hospital, Moscow, Russia with suspected
immunodeficiencies between May 2013 and August 2016. Peripheral blood samples
were sent for TREC/KREC, flow cytometry (CD3, CD4, CD8, and CD19), IgA, IgM, and
IgG analysis. A total of 839 samples were analyzed for using TREC assay and flow
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cytometry and 931 KREC/flow cytometry. TREC demonstrated an AUC of 0.73 (95% CI
0.70–0.76) for CD3, 0.74 (95% CI 0.71–0.77) for CD4 and 0.67 (95% CI 0.63–0.70) for
CD8, respectively, while KREC demonstrated an AUC of 0.72 (95% CI 0.69–0.76) for
CD19. Moderate correlation was found between the levels of TREC and CD4 (r = 0.55,
p < 0.01) and KREC with CD19 (r = 0.56, p < 0.01). In this study, promising prediction
models were tested. We found that TREC and KREC are able to moderately detect
abnormal levels of individual lymphocyte subpopulations. Future research should assess
associations between TREC/KREC and other lymphocyte subpopulations and approach
TREC/KREC use in PID diagnosis.
Keywords: TREC, KREC, primary immune deficiency, PID, flow cytometry, lymphocyte subpopulations,
immunoglobulins
INTRODUCTION
Primary immunodeficiency diseases (PID) is a heterogeneous
group of disorders caused by genetic defects of the immune
system, which manifests clinically as recurrent infections,
autoimmune diseases or malignancies. Severe forms of PID –
Severe Combined Immune Deficiency (SCID) – are associated
with inherited lack of cellular and humoral immunity caused by
mutations in various genes (Chan and Puck, 2005) and associated
with a significant mortality rates in the first 2 years of life (Dvorak
et al., 2013; Yao et al., 2013).
Severe combined immune deficiency can be detected by
T-cell receptor excision circles (TRECs) measurement in a dried
blood spot using real-time polymerase chain reaction (PCR)
(Chan and Puck, 2005). TREC measurement became a part
of neonatal screening in the United States and some other
countries (Verbsky et al., 2012; Kwan et al., 2013). Despite great
predictive value TREC can detect T-cells production defects,
but not isolated B-cell defects. Some experts suggested that
kappa-deleting element recombination circle (KREC) may add
value in PID diagnosis (Nakagawa et al., 2011) and multiplex
techniques for simultaneous quantitation of TREC/KREC were
piloted (Borte et al., 2012).
Outside of neonatal screening, TREC/KREC measurement
is not commonly used in routine clinical practice, with flow
cytometry being a traditional, but more expensive diagnostic
technique for PID detection, when compared with the PCR (Puck
and SCID Newborn Screening Working Group, 2007). It requires
a significant amount of training and not readily available in many
developing countries. TREC and KREC assessment both in PID
diagnosis and in therapy monitoring represent great potential
(Serana et al., 2013).
TREC and KREC predictive ability in SCID has been
extensively studied, but not much research was done in
relation to physiological aspects of relationships between
TREC/KREC and lymphocyte subpopulations. In this pilot
study we assessed correlations between TREC/KREC levels,
lymphocyte subpopulations and immunoglobulins and evaluated
TREC/KREC ability to predict reduced levels of lymphocyte
subpopulations.
MATERIALS AND METHODS
Study Setting, Eligibility Criteria, and
Ethics
We carried out a retrospective analysis of data from all children
assessed by clinical immunologists at Speransky Children’s
Hospital, Moscow, Russia with suspected immunodeficiencies
between May 2013 and August 2016. The diagnosis of different
types of PID was based on IUIS Phenotypic Classification
for Primary Immunodeficiencies (Bousfiha et al., 2015). The
investigations and sample collection have been conducted
following ethical approval by the Speransky Children’s Hospital
Ethics Committee. Parental written consent was obtained for
all participants as a part of routine procedure at Speransky
Children’s Hospital. Parents/guardians were informed of the
procedures in lay terms.
Sample Analysis
Peripheral blood samples were taken by venipuncture during
morning hours, aliquoted and sent for CBC, flow cytometry,
immunoglobulins (IgA, IgM, and IgG) and TREC/KREC
analysis. All blood samples were EDTA-anticoagulated and
analyzed on the same day of the collection in order to avoid
cellular death.
Immunophenotyping
Three-Four color flow cytometric immunophenotyping with
directly labeled monoclonal antibodies was used to determine the
following immune cell subsets: CD3, CD4, CD8, CD19 following
manufacturer’s protocol. In brief, 50 µl aliquots of blood were
incubated for 15 min in the dark at room temperature with
combinations of optimally titrated fluorochrome-conjugated
monoclonal antibodies. After surface staining, erythrocytes were
lysed using 1 ml of BD FACSLysing Solution, diluted according to
manufacturer’s instructions. Remaining cells were washed twice
and suspected in CELL WASH buffer for further analysis for
a FACS Canto II flow cytometer using FACSDiva v7.0 software
(Becton Dickinson). Cell suspension for staining of naïve and
memory B-lymphocytes were prepared as described by Ferry et al.
(2005). Briefly, 300 µl blood aliquots were washed three times
using CELL WASH buffer (Becton Dickinson) supplemented
Frontiers in Physiology | www.frontiersin.org 2 January 2019 | Volume 9 | Article 1877
fphys-09-01877 January 17, 2019 Time: 18:38 # 3
Korsunskiy et al. TREC/KREC and Lymphocyte Subpopulations
with 2% bovine serum albumin to eliminate any cell-bound
antibodies non-specifically inhibiting the staining effect.
Acquisition was run until 10000–50000 events were detected.
First the viable part of the sample was selected by physical
gating based on forward scatter (FS) and side scatter (SS); the
lymphocyte population was identified by the low forward and
side scatter and checked for purity by the positivity for CD45.
Then the different lymphocyte subpopulations were identified
by immunophenotype markers. At least 5000 events from
B-lymphocyte gate set based on CD19 expression and side scatter
characteristics were acquired.
The total leucocytes count and differential was measured with
Advia 2120i hematology analyzer (Siemens). The absolute size
of each lymphocyte subpopulation was calculated by multiplying
the relative size of the lymphocyte subpopulation and the absolute
lymphocyte count.
Immunoglobulins Assay
Immunoglobulin levels were assessed by immunoturbidimetry
method using biochemical analyzer Architect C8000 (Abbott,
United States, Abbott kits) in accordance with manufacturers’
protocol.
TREC and KREC Assay
TREC and KREC assay was performed using real-time PCR with
fluorescent hybridization probes with reagents for TREC/KREC
assay T&B PCR kit (ABV-test, Russia) (Deripapa et al., 2017) in
whole blood and dry blood stain DNAs.
The TREC/KREC levels were assayed in whole blood samples
as described previously (Sottini et al., 2010; Deripapa et al., 2017).
In brief, DNA was extracted from 100 µl EDTA anticoagulated
whole blood by using RIBO-prep nucleic acid extraction kit
(Amplisense R©, Russia). The Real-time qPCR was performed by
using CFX 96 Real-Time PCR System (Bio Rad, United States).
Statistical Analysis
Shapiro-Wilk test has been used to assess the normality of
the distribution of variables analyzed in this paper. Since the
null hypothesis about the normality was rejected, Spearmen
correlation coefficient was used to assess the strength of the
correlation between the variables. Sensitivity, specificity and their
95% confidence intervals were computed with stratified bootstrap
replicates (Carpenter and Bithell, 2000). Area under Receiver
Operating Characteristic (ROC) -curve (AUC) calculation was
followed by 95% confidence interval as suggested by DeLong
(DeLong et al., 1988). To account for non-linear trend, level of
TREC, KREC, and lymphocyte subpopulations were substituted
by the ratio of their concentrations to corresponding reference
values for a given patient age.
Results were considered statistically significant if p-value was
smaller than 0.05. All calculations were done using R package
version 3.4.1.
TREC/KREC and Lymphocyte Subpopulations
Primary analysis consisted of two stages.
At stage 1 we assessed 4 paired relationships between the levels
of TREC with CD3, CD4, CD8, and KREC with CD19. These
TABLE 1 | Characteristics of study participants.
PID type ICD-10 (number of patients) Age Gender
Male Female
Type I D81 (17) 0–12 months 9 5
Immunodeficiencies affecting cellular and humoral immunity 1–6 years 2 0
6–12 years 1 0
12–18 years 0 0
Type II D82 (13) 0–12 months 7 9
CID with associated or syndromic features D82.1 (39) 1–6 years 26 17
D82.4 (5) 6–12 years 10 6
D84.8 (15) 12–18 years 4 3
G11.3 (8)
Type III D80.0 (4) 0–12 months 6 2
Predominantly antibody deficiencies D80.1 (47) 1–6 years 21 17
D80.2 (34) 6–12 years 28 21
D80.3 (24) 12–18 years 38 13
D80.4 (1)
D80.5 (4)
D83 (34)
Healthy children 0–12 months 9 5
1–6 years 41 48
6–12 years 36 33
12–18 years 25 29
Provided codes are in accordance with International Classification of Diseases, 10th revision (ICD-10).
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FIGURE 1 | Receiver operating characteristic (ROC) curves for TREC and KREC for the ability to predict abnormal values of lymphocyte subpopulations (CD3, CD4,
CD8, and CD19), (n = 931).
were presented as a proportion of patients with normal levels of
one of the paired variable among patients with normal levels of
another immunological marker.
We also assessed correlations between TREC/KREC and
lymphocyte subpopulations.
At stage 2 we assessed ability of TREC and KREC to predict
abnormality in lymphocyte subpopulation levels. Using ROC-
analysis the predictivity of TREC, KREC and their combination
was tested providing: (a) the sensitivity (proportion detected of
those with lower lymphocyte subpopulation levels) at a fixed
specificity (proportion of controls correctly detected not to have
reduced lymphocyte subpopulation levels) and (b) AUC.
RESULTS
Study Population
The data was extracted from the clinical notes and laboratory
database of Speransky Children’s Hospital. Out of all 3055
patients requiring flow cytometry within the given period of
time, due to financial restrictions, a total of 839 samples were
analyzed using flow cytometry and TREC assay and 931 samples
were analyzed using flow cytometry and KREC assay and were
included into the statistical analysis. Data on TREC/KREC levels
of 2050 children were unavailable and were not evaluated further.
TABLE 2 | Model performance for different cutoff points of the predicted
probabilities for TREC with regards to CD3.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.5 69 76 97 17 13.7
0.55 76 58 81 50 31.3
0.6 79 51 67 67 32.9
0.65 81 46 52 78 29.2
0.7 85 44 41 86 27.1
0.75 86 41 31 90 21
0.8 88 39 23 94 17.4
Optimum cut-off point based on maximum value of the J index is presented in bold.
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TABLE 3 | Model performance for different cutoff points of the predicted
probabilities for TREC with regards to CD4.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.5 72 76 94 34 27.9
0.55 76 59 77 58 35.1
0.6 79 51 61 71 32
0.65 81 47 48 80 27.9
0.7 83 44 36 87 23.6
0.75 87 42 28 93 20.7
Optimum cut-off point based on maximum value of the J index is presented in bold.
TABLE 4 | Model performance for different cutoff points of the predicted
probabilities for TREC with regards to CD8.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.5 65 64 80 44 24.6
0.55 69 52 48 73 21
0.6 72 48 28 86 14.1
0.65 70 46 18 90 8.4
0.7 72 45 11 95 5.3
Optimum cut-off point based on maximum value of the J index is presented in bold.
TABLE 5 | Model performance for different cutoff points of the predicted
probabilities for KREC with regards to CD19.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.5 71 58 79 48 26.9
0.55 75 54 67 64 30.4
0.6 77 50 55 74 28.2
0.65 80 47 45 82 26.6
0.7 82 46 38 86 23.9
0.75 87 45 33 92 24.5
0.8 91 44 26 96 21.8
Optimum cut-off point based on maximum value of the J index is presented in bold.
Data on clinical diagnosis was available in 471 participant and
presented in Table 1.
Comparison of Flow Cytometry
Parameters With TREC and KREC
At first stage ability of TREC/KREC test to predict CD19, CD3,
CD4 and CD8 flow cytometry results was assessed. We found
that 667 out of 863 (77.3%) patients with normal KREC levels
[as reported earlier (Gordukova et al., 2015)] had normal CD19,
while 667 out of 682 (97.8%) individuals with normal CD19 had
normal KREC.
In patients with normal TREC levels, 462 out of 548 (84.3%)
had normal CD3, 440 out of 548 (80.3%) normal CD4, and
FIGURE 2 | Receiver operating characteristic (ROC) curves for TREC for the
ability to predict abnormal values of lymphocyte subpopulations (CD3, CD4,
and CD8), (n = 839).
FIGURE 3 | Receiver operating characteristic (ROC) curves for combination of
TREC and KREC for the ability to predict abnormal values of lymphocyte
subpopulations (CD3, CD4, CD8, and CD19), (n = 931).
473 out of 548 (86.3%) normal CD8 counts. Individuals having
normal levels of CD3, CD4, and CD8 had normal levels of
TREC in 462/548 (84.3%), 440/548 (80.3%), and 473/548 (86.3%),
respectively.
Values of TREC, KREC and lymphocyte subpopulations which
were considered abnormally low for the purpose of this study are
reported in Supplementary Table S1.
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TABLE 6 | Model performance for different cutoff points of the predicted
probabilities for TREC with regards to CD3,4, and 8.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.4 55 68 59 65 23
0.45 55 61 28 83 10.7
0.5 56 59 17 90 6.7
Optimum cut-off point based on maximum value of the J index is presented in bold.
TABLE 7 | Model performance for different cutoff points of the predicted
probabilities for combined TREC and KREC with regards o all lymphocyte
subpopulations measured.
Cutoff
(probability) PPV NPV Sensitivity Specificity Youden
(probability) (%) (%) (%) (%) index
0.3 43 85 93 24 17.3
0.35 48 71 61 59 20.2
0.4 52 68 43 75 18.2
0.45 54 66 28 86 13
0.55 65 64 13 96 8.5
Optimum cut-off point based on maximum value of the J index is presented in bold.
TREC/KREC Ability to Predict Abnormal
Levels in Lymphocyte Subpopulations
We assessed TREC/KREC ability to predict each lymphocyte
subpopulation individually, using area under the curve (AUC),
which are shown in Figure 1. TREC demonstrated an AUC of
0.73 (95% CI 0.70–0.76) for CD3, 0.74 (95% CI 0.71–0.77) for
CD4 and 0.67 (95% CI 0.63–0.70) for CD8, respectively, while
KREC demonstrated an AUC of 0.72 (95% CI 0.69–0.76) for
CD19.
The following cutoff points of a probability showed the best
prognostic accuracy with regards to sensitivity and specificity for
TREC: 0.6 (67% for both, sensitivity, and specificity; Table 2),
Youden’s index (J) = 32.9 in CD3; 0.55 (77 and 58%; Table 3),
J = 35.1 in CD4; 0.5 (80 and 44%; Table 4), J = 24.6 in CD8,
respectively. A cutoff point of a probability of 0.55 showed the
best diagnostic accuracy with regards to sensitivity and specificity
for KREC (67% and 64%; Table 5), J = 30.4 in predicting
abnormal levels of CD19.
We also assessed AUC for TREC ability to predict the reduced
levels of CD3, CD4 and CD8 (Figure 2), and a combination
of TREC and KREC (Figure 3) to predict the reduced levels
of all lymphocyte subpopulations analyzed. TREC demonstrated
an AUC of 0.66 (95% CI 0.63–0.70) while a combination of
TREC and KREC resulted in an AUC of 0.65 (95% CI 0.62–0.69).
A cutoff point of a probability of 0.4 showed the best diagnostic
accuracy with regards to sensitivity and specificity for TREC (59%
and 65%; Table 6), J = 23 and 0.35 for a combination of TREC and
KREC (61 and 59%, respectively; Table 7), J = 20.2.
Correlation Between TREC/KREC and
Lymphocyte Subpopulations
We observed a moderate correlation (Table 8) between the levels
of TREC and CD4 (r = 0.55, p < 0.01) and KREC with CD19
(r = 0.56, p < 0.01). Moderate to low correlation was found
between TREC with CD19, CD3 and lymphocytes (r between
0.28 and 0.46, p < 0.01) and KREC with CD4 and lymphocytes
(r = 0.33, p < 0.01). Neither TRECs nor KRECs levels correlated
with the concentration of immunoglobulins (IgA, IgG).
DISCUSSION
In this study, we assessed associations between TREC/KREC and
lymphocyte subpopulations. TREC and KREC models showed
good ability to predict abnormal levels of certain lymphocyte
subpopulations and modest correlations between TREC and
CD4, KREC and CD19 were found.
PID is a large group of disorders encompassing a few hundred
various conditions affecting development and/or functioning of
the immune system (Picard et al., 2015). Flow cytometry is
a sensitive and important tool in immune system functioning
evaluation and PID diagnosis (Kanegane et al., 2018), however,
it is expensive, not easily available and complexity of the
method requires appropriate training. TREC and KREC may
represent a cheaper alternative and/or add value to PID diagnosis
and screening. Low cost methodology can be used in small
laboratories and rural settings, where complex and expensive
tools are unavailable, to provide access to primary PID evaluation.
TREC/KREC evaluation may also serve as a prerequisite to flow
cytometry.
We found significant correlations between the levels of TREC
and lymphocyte subpopulations with the strongest correlations
were observed for TREC/CD3, TREC/CD4. This finding is
consistent with previous reports (Mensen et al., 2013; Gul et al.,
2015), suggesting that low TREC levels correlate with low values
of CD3+ and CD4+. The observed positive correlation could
be attributed to TRECs being a direct marker for thymic output
(Ravkov et al., 2017). We also observed a statistically significant
moderate KREC levels correlation with CD19 levels and we
are not aware of other studies reporting this finding, however
TABLE 8 | Heatmap of correlation between TRECs/KRECs level with immunoglobulins, CDs and blood cells.
ley lym IgG IgA IgM CD4 CD8 CD3 CD19
TREC 0.09∗∗ 0.41∗∗ −0.08∗ −0.11∗∗ 0.002NS 0.55∗∗ 0.28∗∗ 0.46∗∗ 0.34∗∗
KREC 0.11∗∗ 0.33∗∗ −0.17∗∗ −0.15∗∗ −0.10∗∗ 0.33∗∗ 0.12∗∗ 0.25∗∗ 0.56∗∗
More intense green color means stronger positive correlations, while more intense red color means stronger negative correlation. ∗p < 0.05; ∗∗p < 0.01; NS, statistically
not significant result.
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correlation is plausible as both KREC and CD19 are linked with
B-lymphocytes.
When proportion of patients with both normal TREC/KREC
and lymphocyte subpopulations was assessed, we found that
almost every individual with CD19 within the reference range
had normal KREC levels. Most of individuals (80–85%) with
CD3, CD4 and CD8 within the reference range had normal TREC
levels. Given moderate correlations between TREC/KREC and
lymphocyte subpopulations and promising proportion results,
we expected a decent ability of TREC and KREC predictive
models with regards to lymphocyte subpopulations abnormal
levels. Positive predictive values for TREC ability to predict
abnormal levels of CD3 and CD4, and KREC abnormal levels
of CD19 varied between 75 and 79%, when optimum cut-off
point was selected based on maximum value of the J index.
TREC ability to predict abnormal level of CD8, in contrast, was
much lower and reached a PPV of 65% only. This result was not
surprising as negligible correlation between TREC and CD8 levels
was detected.
Neither TREC, nor a combination of TREC and KREC
reached impressive AUC values when predictivity of cumulative
lymphocyte subpopulations was modeled. A cut-off points of a
probability of 0.4 for TREC and 0.35 for a combination of TREC
and KREC showed the best diagnostic accuracy according to
Youden’s index but positive predictive value of the models was
very low. We may speculate that lack of individual and multiple
correlations between TREC and CD8; KREC and CD3, CD8,
may explain lack of consistency in the model performance, when
predictivity in relation to cumulative lymphocyte subpopulations
was tested.
Models showed promising ability of TREC to predict
abnormal levels of CD3 and CD4, and KREC abnormal levels
of CD19. Although combined use of TREC and KREC did
not result in good predictivity when cumulative lymphocyte
subpopulations were assessed, further research may improve
predictive ability, adding other subpopulations, such as naïve
B-lymphocytes CD19+CD27-IgD+, recent thymic emigrants
(RTE) and CD31+CD45RA+ T-lymphocytes. PID is a very
heterogenous group of diseases, and TREC/KREC predictive
abilities should be further tested in individuals with separate PID
conditions. Future research should also target investigation of
TREC/KREC diagnostic abilities in PID patients, which is an
existing unmet need.
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